Navigation Links
ABRISA Appoints Jim Veler as President/CEO
Date:9/10/2009

SANTA PAULA, Calif., Sept. 10 /PRNewswire/ -- Abrisa, Inc., a global leader in industrial glass fabrication products and precision thin film optical coatings, recently named industry veteran Jim Veler as President and Chief Executive Officer. The appointment became effective June 1, 2009.

Prior to joining Abrisa, Mr. Veler was Vice President and General Manager of Agilent Technologies' Wireless Manufacturing Organization (Santa Rosa, CA). His duties included the management of 1600 employees and full responsibility for the manufacturing operations of two semiconductor fabs as well as Agilents' Aerospace Defense Systems' business.

Jim Veler notes, "My vision is to transform Abrisa from its roots as a respected global leader of high-volume industrial glass fabrication to an innovator in providing precision optical product solutions. While we will be focusing on several markets, we are targeting substantial growth in four key segments: defense, medical, display, and lighting. Abrisa has gained tremendous momentum with our two recent acquisitions and we plan to acquire at least one more company to help us better serve these strategic markets."

"What makes Veler an excellent choice for the Abrisa helm is his vast experience in the thin film industry," says Mr. Tom Portland, Chairman of the Abrisa Board. He adds, "Jim rose to the level of Vice President and General Manager of the Custom Optics Products Group, the legacy Optical Coating Laboratory Inc. (OCLI) business, now part of JDS Uniphase (Santa Rosa, CA). In his role at OCLI, he managed all aspects of the business including sales, marketing, R&D, business development, and operations. Jim brings his experience at OCLI to his new role here at Abrisa. Jim has already taken his first steps towards achieving his vision by hiring two industry-renowned sales managers. Jim Hooker (previously with Deposition Sciences and Optical Coating Laboratori
'/>"/>

SOURCE Abrisa, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
2. Hovione Appoints Terry Lambe to its Board of Directors
3. Sechrist Increases Focus on International Markets; Appoints William Preuit Senior Vice President
4. China Biologic Products Appoints Director of Research and Development
5. PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director
6. iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer
7. Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
8. ERT Appoints New Associate Director of Business Development - Japan
9. NeurogesX Appoints New Board Director and Audit Committee Chairman
10. Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
11. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 The third edition of ... , published by the Infusion Nurses Society ... anthracycline extravasation.(1) Anthracyclines are a group of ... that have been used in the treatment of ... ,, According to the INS publication: ...
(Date:12/14/2009)... Dec. 14 Lionbridge (Nasdaq: ... signed a new, three-year master services agreement ... products and services that serve patients in ... will become the sole provider for translation ... regulatory, marketing, training, human resources, legal, and ...
(Date:12/14/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, owing to the launches ... market will increase more than sevenfold from $790 ... in the United States, France, Germany, Italy, Spain, ... Pharmacor report entitled Atrial Fibrillation finds ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB ... Industrialized Countries , , - A third ... impacts their enjoyment of the festive ... find shopping for gifts, preparing ... difficult to do, - ...
Breaking Biology Technology:Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4
... Inc. (Nasdaq:,FVRL), a biopharmaceutical company developing patient-specific, active,immunotherapies ... it will,host a conference call and live webcast ... 2007 to discuss the Company,s third quarter 2007,financial ... 2007,financial results will be issued before the U.S. ...
... SOUTH SAN FRANCISCO, Calif., Oct. 16 Rigel,Pharmaceuticals, ... its scientists,will be presenting three poster presentations at ... Therapeutics in,San Francisco, October 22-26, 2007. They will ... including Axl receptor,tyrosine kinase (Axl), Polo- like kinase ...
... N.J., Oct. 16 National Stem,Cell Holding, Inc. ... patent application for a newly discovered group of,biomaterials, ... cell,lines, that may stimulate a variety of naturally ... ability to preserve and repair,itself . These ...
Other Biology Technology:Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25, 2007 2Rigel to Present Research Programs at Scientific Conferences 2Rigel to Present Research Programs at Scientific Conferences 3National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 2National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 3
(Date:12/14/2009)... are spending the holidays with big Uncle Frank or ... better off with another family, spare a thought for ... from McMaster University and the University of New South ... lives in groups, members make strategic decisions about their ... current issue of Biology Letters . , The ...
(Date:12/14/2009)... laparoscopy is in preventing some of the stresses of open ... blood flow and organ dysfunction. Laparoscopy is a type of ... , By adding another gas to the carbon ... at Duke University Medical Center have found they can preserve ... gas ethyl nitrite (ENO) helped to open blood vessels and ...
(Date:12/13/2009)... 2009Researchers at The Scripps Research Institute have solved ... from an ancient family of enzymes can have ... addition to providing guidance for understanding other molecules ... underpinning for the protein,s possible use for combating ... research was published in the December 13, 2009 ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3University of Toronto helps to barcode the worlds plants 9394 1University of Toronto helps to barcode the worlds plants 9394 2Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 1Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
... release is available in French . ... stunt growth and foster weight gain during puberty, according ... of Clinical Endocrinology & Metabolism . Even in sun-drenched ... (MUHC) and the University of Southern California conducted their ...
... group of drugs commonly used to treat diabetes can double ... new study by the University of East Anglia (UEA) and ... Medical Association Journal (CMAJ) , the findings show that use ... type 2 diabetes significantly reduces bone density, resulting in the ...
... N.Y. Fads have been a staple of American pop ... jeans today. But while going from fad to flop may ... suggests that this is exactly what should be expected for ... research, led by cognitive scientist Mark Changizi of Rensselaer Polytechnic ...
Other Biology News:Lack of vitamin D causes weight gain and stunts growth in girls 2Long-term use of diabetes drugs by women significantly increases risk of fractures 2Study reveals effects of unconscious exposure to advertisements 2
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
... This CLS number ... number, created to easily ... If showing no availability ... the old Sigma-Aldrich number ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
... pressure gradient system uses three Adept CE ... a flow rate in one microlitre increaments. ... added flexibility. System control and data processing ... interface unit, CE 4900., Column heater/chillers can be ...
Biology Products: